綠康生化(002868.SZ):2021年非公開發行股票相關決議有效期及相關授權有效期擬延期
格隆匯1月18日丨綠康生化(002868.SZ)公佈,鑑於公司2021年第一次臨時股東大會審議的公司本次非公開發行股票的決議有效期將要到期,為確保本次非公開發行事宜的順利推進,公司於2022年1月17日召開了第四屆董事會第六次(臨時)會議,審議通過了《關於提請股東大會同意延長公司非公開發行A股股票股東大會決議有效期及股東大會授權董事會及董事會授權人士辦理相關事宜有效期的議案》,於2022年1月17日召開了第四屆監事會第五次會議,審議通過了《關於延長公司非公開發行A股股票股東大會決議有效期及股東大會授權董事會及董事會授權人士辦理相關事宜有效期的議案》。同意將公司非公開發行股票決議的有效期和授權董事會全權辦理本次非公開發行股票相關事宜的有效期延長至2023年2月18日。
除延長上述決議有效期及授權有效期外,公司非公開發行股票的其他事項內容保持不變。
公司上述關於非公開發行股票決議有效期及相關授權有效期延期的議案尚需提交公司2022年第一次臨時股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.